Identifying Endometrial Delay Improves Treatment Outcome in Women with Thin Endometrium and Infertility
DOI:
https://doi.org/10.24079/cajms.2024.02.003Keywords:
Endometrium, Delay, Maturation, Receptivity, Reproductive Outcome, PregnancyAbstract
Objective: To determine the impact of endometrial delay on reproductive outcomes.
Method: We enrolled 62 infertility women with thin endometrium pre- and post-study in 2020-2023. Infertile women with an endometrial thickness of <7 mm were included and followed in the study. All participants had endometrial delay determined and adjusted before initial Assisted reproductive technologies (ART). After, infertility treatment was started. ART outcomes were evaluated by endometrial thickness and implantation rate. Endometrial thickness was compared to pre-hormone replacement treatment at 48 and 72 hours post-hormone therapy. Results: The study included 62 women aged 26-45 who were diagnosed with infertility and thin endometrium. Endometrial thickness was sufficiently increased before and after treatment for all participants. Histological analysis diagnosed endometrial delay (not appropriate WOI) in 73.6% of all women. After adjusting the WOI in study participants, there was a statistically significant increase in endometrial thickness post-hormone replacement therapy. The study participants were women who had failed at least one implantation, and the implantation rate after WOI adjustment was 58.5%. Conclusions: In 70% of infertility women, endometrial is delayed. In women with thin endometrium, the precise determination of WOI increases ART treatment outcomes.
Downloads
48
References
1. Günther V, Otte SV, Freytag D, et al. Recurrent implantation failure - an overview of current research. Gynaecol Endocrinol. 2021;37(7):584–590. https://doi.org/10.1080/.2021.1878136
2. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99(1):63. https://doi.org/10.1016/j.fertnstert.2012.09.023
3. Hong LiY, Marren A. Recurrent pregnancy loss: A summary of international evidence-based guidelines and practice. Aust J Gen Prac. 2018;47(7):432–436. https://doi.org/10.31128/AJGP-01-18-4459
4. El Hachem H, Carpeaux V, May-Panloup P, et al. Recurrent pregnancy loss: current perspectives. Int J Womens Health. 2017;9:331–345. https://doi.org/10.2147/IJWH.S100817
5. Voss P, Schick M, Langer L, et al. Recurrent pregnancy loss: a shared stressor---couple-orientated psychological research finding. Fertil Steril. 2020;114(6):1288–1296. https://doi.org/10.1016/j.fertnstert.2020.08.1421
6. Al-Lamee H, Hill CJ, Turner F, et al. The Role of Endometrial Stem/Progenitor Cells in Recurrent Reproductive Failure. J Pers Med. 2022;12(5):775. https://doi.org/10.3390/jpm12050775
7. Panagiotopoulou N, Karavolos S, Choudhary M. Endometrial injury before assisted reproductive techniques for recurrent implantation failure: a systematic literature review. Eur J Obstet Gynecol Reprod Biol. 2015;193:27–33. https://doi.org/10.1016/j.ejogrb.2015.06.026
8. Rumi MAK, Singh P, Roby KF, et al. Defining the Role of Estrogen Receptor β in the Regulation of Female Fertility. Endocr. 2017;158(7):2330–2343. https://doi.org/10.1210/en.2016-1916
9. Hapangama DK, Kamal AM, Bulmer JN. Estrogen receptor β: the guardian of the endometrium. Hum Reprod Update. 2015;21(2):174–193. https://doi.org/10.1093/humupd/dmu053
10. Alfer J, Happel L, Dittrich R, et al. Insufficient Angiogenesis: Cause of Abnormally Thin Endometrium in Subfertile Patients? Geb Fra. 2017;77(7):756–764. https://doi.org/10.1055/s-0043-111899
11. Haas DM, Hathaway TJ, Ramsey PS. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst Rev. 2019;(11):CD003511. https://doi.org/10.1002/14651858.CD003511.pub5
12. Wang A, Ji L, Shang W, et al. Expression of GPR30, Erα, and ERβ in the endometrium during the window of implantation in patients with polycystic ovary syndrome: a pilot study. J Gynaecol Endocrinol. 2011;27(4):251–255. https://doi.org/10.3109/09513590.2010.487584
13. Makker A, Tandon I, Goel MM, et al. Effect of ormeloxifene, a selective estrogen receptor modulator, on biomarkers of endometrial receptivity and propose the development and its relation to fertility and infertility in Indian subjects. Fertil Steril. 2009;91(6):2298–2307. https://doi.org/10.1016/j.fertnstert.2008.04.018
14. Al-Lamee H, Ellison A, Drury J, et al. Altered endometrial oestrogen-responsiveness and recurrent reproductive failure. Reprod Fertil. 2022;3(1):30–38. https://doi.org/10.1530/RAF-21-0093
15. Enciso M, Aizpurua J, Rodríguez-Estrada B, et al. The precise determination of the window of implantation significantly improves ART outcomes. Sci Rep. 2021;11(1):13420. https://doi.org/10.1038/s41598-021-92955-w
16. Eftekhar M, Mehrjardi SZ, Molaei B. et al. The correlation between endometrial thickness and pregnancy outcomes in fresh ART cycles with different age groups: a retrospective study. Middle East Fertil Soc J. 2020;24:10. https://doi.org/10.1186/s43043-019-0013-y
17. Mahajan N, Sharma S. The endometrium in assisted reproductive technology: How thin is thin? J Hum Reprod Sci. 2016;9(1):3–8. https://doi.org/10.4103/0974-1208.178632
18. Abdalla HI, Brooks AA, Johnson MR, et al. Endometrial thickness: a predictor of implantation in ovum recipients? Hum Reprod. 1994;9(2):363–365. https://doi.org/10.1093 oxfordjournals.humrep.a138509
19. El-Toukhy T, Coomarasamy A, Khairy M, et al. The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles. Fertil Steril. 2008;89(4):832–839. https://doi.org/10.1016/j.fertnstert.2007.04.031
20. Tomic V, Kasum M, Vucic K. Impact of embryo quality and endometrial thickness on implantation in natural cycle IVF. Arch Gynaecol Obstet. 2020;301(5):1325–1330. https://doi.org/10.1007/s00404-020-05507-4
21. Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35(5):753–756. https://doi.org/10.1007/s10815-018-1159-8
22. Bos-Mikich A, Ferreira MO, de Oliveira R, et al. Platelet-rich plasma or blood-derived products to improve endometrial receptivity? J Assist Reprod Genet. 2019;36(4):613–620. https://doi.org/10.1007/s10815-018-1386-z
23. Urman B, Boza A, Balaban B. Platelet-rich plasma another add-on treatment getting out of hand? How can clinicians preserve the best interests of their patients? Hum Reprod. 2019;34(11):2099–2103. https://doi.org/10.1093/humrep/dez190
24. Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol. 2010;225(3):757–766. https://doi.org/10.1002/jcp.22274
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mongolian National University of Medical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.